HLA-DOA antibody (N-Term)
Quick Overview for HLA-DOA antibody (N-Term) (ABIN6258910)
Target
See all HLA-DOA AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Purpose
- HLA-DOA Antibody
-
Specificity
- HLA-DOA Antibody detects endogenous levels of total HLA-DOA
-
Predicted Reactivity
- Horse,Sheep
-
Purification
- The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
-
Immunogen
- A synthesized peptide derived from human HLA-DOA, corresponding to a region within N-terminal amino acids.
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB 1:500-1:1000, IF/ICC 1:100-1:500
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C. Stable for 12 months from date of receipt.
-
Expiry Date
- 12 months
-
-
- HLA-DOA (HLA Class II DO alpha (HLA-DOA))
-
Alternative Name
- HLA-DOA
-
Background
-
Description: Important modulator in the HLA class II restricted antigen presentation pathway by interaction with the HLA-DM molecule in B-cells. Modifies peptide exchange activity of HLA-DM.
Gene: HLA-DOA
-
Molecular Weight
- 34 kDa
-
Gene ID
- 3111
-
UniProt
- P06340
-
Pathways
- Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Target
-